130 related articles for article (PubMed ID: 25526629)
1. The synergistic repressive effect of NF-κB and JNK inhibitor on the clonogenic capacity of Jurkat leukemia cells.
Liu X; Zhang J; Li J; Volk A; Breslin P; Zhang J; Zhang Z
PLoS One; 2014; 9(12):e115490. PubMed ID: 25526629
[TBL] [Abstract][Full Text] [Related]
2. Co-inhibition of NF-κB and JNK is synergistic in TNF-expressing human AML.
Volk A; Li J; Xin J; You D; Zhang J; Liu X; Xiao Y; Breslin P; Li Z; Wei W; Schmidt R; Li X; Zhang Z; Kuo PC; Nand S; Zhang J; Chen J; Zhang J
J Exp Med; 2014 Jun; 211(6):1093-108. PubMed ID: 24842373
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of TPA-induced growth inhibition and apoptosis in myeloid leukemia cells by BAY 11-7082, an NF-kappaB inhibitor.
Hansson A; Marín YE; Suh J; Rabson AB; Chen S; Huberman E; Chang RL; Conney AH; Zheng X
Int J Oncol; 2005 Oct; 27(4):941-8. PubMed ID: 16142309
[TBL] [Abstract][Full Text] [Related]
4. Blockade of histone deacetylase inhibitor-induced RelA/p65 acetylation and NF-kappaB activation potentiates apoptosis in leukemia cells through a process mediated by oxidative damage, XIAP downregulation, and c-Jun N-terminal kinase 1 activation.
Dai Y; Rahmani M; Dent P; Grant S
Mol Cell Biol; 2005 Jul; 25(13):5429-44. PubMed ID: 15964800
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways.
Scupoli MT; Donadelli M; Cioffi F; Rossi M; Perbellini O; Malpeli G; Corbioli S; Vinante F; Krampera M; Palmieri M; Scarpa A; Ariola C; Foà R; Pizzolo G
Haematologica; 2008 Apr; 93(4):524-32. PubMed ID: 18322253
[TBL] [Abstract][Full Text] [Related]
6. Sensitizing leukemia stem cells to NF-κB inhibitor treatment in vivo by inactivation of both TNF and IL-1 signaling.
Li J; Volk A; Zhang J; Cannova J; Dai S; Hao C; Hu C; Sun J; Xu Y; Wei W; Breslin P; Nand S; Chen J; Kini A; Zhu J; Zhang J
Oncotarget; 2017 Jan; 8(5):8420-8435. PubMed ID: 28039479
[TBL] [Abstract][Full Text] [Related]
7. Eriocalyxin B induces apoptosis of t(8;21) leukemia cells through NF-kappaB and MAPK signaling pathways and triggers degradation of AML1-ETO oncoprotein in a caspase-3-dependent manner.
Wang L; Zhao WL; Yan JS; Liu P; Sun HP; Zhou GB; Weng ZY; Wu WL; Weng XQ; Sun XJ; Chen Z; Sun HD; Chen SJ
Cell Death Differ; 2007 Feb; 14(2):306-17. PubMed ID: 16778832
[TBL] [Abstract][Full Text] [Related]
8. Proteasome inhibitors potentiate leukemic cell apoptosis induced by the cyclin-dependent kinase inhibitor flavopiridol through a SAPK/JNK- and NF-kappaB-dependent process.
Dai Y; Rahmani M; Grant S
Oncogene; 2003 Oct; 22(46):7108-22. PubMed ID: 14562039
[TBL] [Abstract][Full Text] [Related]
9. CpG ODN-induced matrix metalloproteinase-13 expression is mediated via activation of the ERK and NF-κB signalling pathways in odontoblast cells.
Zhang J; Zhu QL; Huang P; Yu Q; Wang ZH; Cooper PR; Smith AJ; He W
Int Endod J; 2013 Jul; 46(7):666-74. PubMed ID: 23331101
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological inhibitors of NF-kappaB accelerate apoptosis in chronic lymphocytic leukaemia cells.
Pickering BM; de Mel S; Lee M; Howell M; Habens F; Dallman CL; Neville LA; Potter KN; Mann J; Mann DA; Johnson PW; Stevenson FK; Packham G
Oncogene; 2007 Feb; 26(8):1166-77. PubMed ID: 16924235
[TBL] [Abstract][Full Text] [Related]
11. HA14-1 sensitizes TNF-alpha-induced apoptosis via inhibition of the NF-kappaB signaling pathway: involvement of reactive oxygen species and JNK.
Moon DO; Kim MO; Kang SH; Choi YH; Park SY; Kim GY
Cancer Lett; 2010 Jun; 292(1):111-8. PubMed ID: 20022690
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of TLR-4, NF-κB, and SAPK/JNK signaling reduce the toxic effect of lipopolysaccharide on RAW 264.7 cells.
Glushkova OV; Parfenyuk SB; Khrenov MO; Novoselova TV; Lunin SM; Fesenko EE; Novoselova EG
J Immunotoxicol; 2013; 10(2):133-40. PubMed ID: 22830990
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
14. Synergistic therapeutic effect of diethylstilbestrol and CX-4945 in human acute T-lymphocytic leukemia cells.
Jung JI; Park KY; Kim SA; Kim J
Biomed Pharmacother; 2018 Feb; 98():357-363. PubMed ID: 29275177
[TBL] [Abstract][Full Text] [Related]
15. JNK/AP-1 activation contributes to tetrandrine resistance in T-cell acute lymphoblastic leukaemia.
Liou JT; Lin CS; Liao YC; Ho LJ; Yang SP; Lai JH
Acta Pharmacol Sin; 2017 Aug; 38(8):1171-1183. PubMed ID: 28603286
[TBL] [Abstract][Full Text] [Related]
16. RNF187 is Downregulated Following NF-κB Inhibition in Late Erythroblasts.
Forster L; Finlayson J; Ghassemifar R
Biochem Genet; 2016 Oct; 54(5):714-21. PubMed ID: 27259582
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis induced by trimethyltin chloride in human neuroblastoma cells SY5Y is regulated by a balance and cross-talk between NF-κB and MAPKs signaling pathways.
Qing Y; Liang Y; Du Q; Fan P; Xu H; Xu Y; Shi N
Arch Toxicol; 2013 Jul; 87(7):1273-85. PubMed ID: 23423712
[TBL] [Abstract][Full Text] [Related]
18. Internalization of Staphylococcus aureus by bovine endothelial cells is associated with the activity state of NF-kappaB and modulated by the pro-inflammatory cytokines TNF-alpha and IL-1beta.
Oviedo-Boyso J; Barriga-Rivera JG; Valdez-Alarcón JJ; Bravo-Patiño A; Cárabez-Trejo A; Cajero-Juárez M; Baizabal-Aguirre VM
Scand J Immunol; 2008 Feb; 67(2):169-76. PubMed ID: 18201371
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-25-induced chemokines and interleukin-6 release from eosinophils is mediated by p38 mitogen-activated protein kinase, c-Jun N-terminal kinase, and nuclear factor-kappaB.
Wong CK; Cheung PF; Ip WK; Lam CW
Am J Respir Cell Mol Biol; 2005 Aug; 33(2):186-94. PubMed ID: 15860795
[TBL] [Abstract][Full Text] [Related]
20. Bortezomib sensitivity of acute myeloid leukemia CD34(+) cells can be enhanced by targeting the persisting activity of NF-κB and the accumulation of MCL-1.
Bosman MC; Schuringa JJ; Quax WJ; Vellenga E
Exp Hematol; 2013 Jun; 41(6):530-538.e1. PubMed ID: 23416210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
